Search Results - "Morse, A. M."

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer by Cohen, S.J., Punt, C.J.A., Iannotti, N., Saidman, B.H., Sabbath, K.D., Gabrail, N.Y., Picus, J., Morse, M.A., Mitchell, E., Miller, M.C., Doyle, G.V., Tissing, H., Terstappen, L.W.M.M., Meropol, N.J.

“…Background: We demonstrated that circulating tumor cell (CTC) number at baseline and follow-up is an independent prognostic factor in metastatic colorectal…”
Get full text

Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer by Aggarwal, C., Meropol, N.J., Punt, C.J., Iannotti, N., Saidman, B.H., Sabbath, K.D., Gabrail, N.Y., Picus, J., Morse, M.A., Mitchell, E., Miller, M.C., Cohen, S.J.

“…We previously reported results of a prospective trial evaluating the significance of circulating tumor cells (CTCs) in patients with metastatic colorectal…”
Get full text

Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti‐programmed cell death 1 therapy by Marano, A.L., Clarke, J.M., Morse, M.A., Shah, A., Barrow, W., Selim, M.A., Hall, R.P., Cardones, A.R.

“…Summary Programmed cell death 1 (PD‐1) blockade has rapidly emerged as an effective therapy for a wide variety of metastatic malignancies. It has been…”
Get full text

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA CD3-bispecific T-cell-engaging BiTE antibody by Osada, T, Hsu, D, Hammond, S, Hobeika, A, Devi, G, Clay, T M, Lyerly, H K, Morse, M A

“…Background: Novel technologies to redirect T-cell killing against cancer cells are emerging. We hypothesised that metastatic human colorectal cancer (CRC)…”
Get full text

ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers by Sinnathamby, G, Zerfass, J, Hafner, J, Block, P, Nickens, Z, Hobeika, A, Secord, A.A, Lyerly, H.K, Morse, M.A, Philip, R

“…Selection of suitable antigens is critical for the development of cancer vaccines. Most desirable are over-expressed cell surface proteins that may serve as…”
Get full text

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142 by André, T., Lonardi, S., Wong, K.Y.M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M.A., Van Cutsem, E., McDermott, R., Hill, A., Sawyer, M.B., Hendlisz, A., Neyns, B., Abdullaev, S., Memaj, A., Lei, M., Dixon, M., Kopetz, S., Overman, M.J.

“…In the phase II multicohort CheckMate 142 study, nivolumab plus low-dose (1 mg/kg) ipilimumab provided robust and durable clinical benefit with a manageable…”
Get full text

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry by Fishman, M., Dutcher, J. P., Clark, J. I., Alva, A., Miletello, G. P., Curti, B., Agarwal, Neeraj, Hauke, R., Mahoney, K. M., Moon, H., Treisman, J., Tykodi, S. S., Daniels, G., Morse, M. A., Wong, M. K. K., Kaufman, H., Gregory, N., McDermott, D. F.

“…Background Prognostic scoring systems are used to estimate the risk of mortality from metastatic renal cell carcinoma (mRCC). Outcomes from different therapies…”
Get full text

Migration of human dendritic cells after injection in patients with metastatic malignancies by MORSE, M. A, COLEMAN, R. E, AKABANI, G, NIEHAUS, N, COLEMAN, D, LYERLY, H. K

“…Present clinical studies of active immunotherapy for malignancies using dendritic cells (DCs) require elucidation of the sites where DCs localize after…”
Get full text

A Phase I Study of Active Immunotherapy with Carcinoembryonic Antigen Peptide (CAP-1)-pulsed, Autologous Human Cultured Dendritic Cells in Patients with Metastatic Malignancies Expressing Carcinoembryonic Antigen by Morse, M A, Deng, Y, Coleman, D, Hull, S, Kitrell-Fisher, E, Nair, S, Schlom, J, Ryback, M E, Lyerly, H K

“…Dendritic cells (DCs), antigen-presenting cells capable of priming naive T cells to specific antigens in an HLA-restricted fashion, have been demonstrated to…”
Get full text

Cancer chemoprevention: principles and prospects by Morse, M A, Stoner, G D

Get more information

Liver metastases from breast cancer: Long-term survival after curative resection by Selzner, Markus, Morse, Michael A., Vredenburgh, James J., Meyers, William C., Clavien, Pierre-Alain

“…Background: Liver metastases from breast cancer are associated with a poor prognosis (median survival <6 months). A subgroup of these patients with no…”
Get full text

Induction of carcinoembryonic antigen (cea)‐specific cytotoxic t‐lymphocyte responses In vitro using autologous dendritic cells loaded with cea peptide or cea rna in patients with metastatic malignancies expressing cea by Nair, Smita K., Hull, Shelley, Coleman, Doris, Gilboa, Eli, Lyerly, H. Kim, Morse, Michael A.

“…The application of dendritic cells (DC) to the active immunotherapy of cancer currently relies on the generation of potent DC capable of presenting tumor…”
Get full text

X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity by Evans, M K, Sauer, S J, Nath, S, Robinson, T J, Morse, M A, Devi, G R

“…Inflammatory breast cancer (IBC) is the deadliest, distinct subtype of breast cancer. High expression of epidermal growth factor receptors [EGFR or human…”
Get full text

A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-γ treatment by Mosca, Paul J., Hobeika, Amy C., Clay, Timothy M., Nair, Smita K., Thomas, Elaine K., Morse, Michael A., Lyerly, H. Kim

“…Dendritic cells (DCs) may arise from multiple lineages and progress through a series of intermediate stages until fully mature, at which time they are capable…”
Get full text

Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS) by Zhao, Y., Qiao, G., Wang, X., Song, Y., Zhou, X., Jiang, N., Zhou, L., Huang, H., Zhao, J., Morse, M. A., Hobeika, A., Ren, J., Lyerly, H. K.

“…Background Advanced non-small cell lung cancer (NSCLC) has remained challenging to treat effectively. This study aimed to investigate the clinical effects and…”
Get full text

Improved experimental data processing for UHPLC–HRMS/MS lipidomics applied to nonalcoholic fatty liver disease by Patterson, R. E., Kirpich, A. S., Koelmel, J. P., Kalavalapalli, S., Morse, A. M., Cusi, K., Sunny, N. E., McIntyre, L. M., Garrett, T. J., Yost, R. A.

“…Introduction Untargeted metabolomics workflows include numerous points where variance and systematic errors can be introduced. Due to the diversity of the…”
Get full text

Molecular Basis for Cell Tropism of CXCR4-Dependent Human Immunodeficiency Virus Type 1 Isolates by Tokunaga, K, Greenberg, M L, Morse, M A, Cumming, R I, Lyerly, H K, Cullen, B R

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer by Stoner, Gary D., Morse, Mark A.

“…A group of arylalkyl isothiocyanates were tested for their abilities to inhibit tumorigenicity and DNA methylation induced by both the tobacco-specific…”
Get full text

Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal by Chung, F L, Morse, M A, Eklind, K I, Lewis, J

“…Our previous studies showed that phenethyl isothiocyanate (PEITC), a cruciferous vegetable constituent, inhibited the lung tumorigenesis induced by a potent…”
Get full text

Changes in mitogen‐activated protein kinase activity occur in the maize pulvinus in response to gravistimulation and are important for the bending response by CLORE, A. M., TURNER, W. S., MORSE, A. M., WHETTEN, R. W.

“…ABSTRACT The maize (Zea mays L.) pulvinus was used as a model system to study the signalling events that lead to differential growth in response to…”
Get full text